AGILENT TECHNOLOGIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 140.2 USD | -0.36% |
|
-2.94% | +0.86% |
| Apr. 09 | Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed | RE |
| Apr. 09 | Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products:
- electronic measurement instruments;
- bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products;
- measurement instruments for semiconductors.
Net sales break down by source of income between sales of products (73.9%) and services (26.1%).
Net sales are distributed geographically as follows: the United States (40%), China (34.3%) and other (25.7%).
Calendar
2024-05-20
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
140.2
USD
Average target price
149.9
USD
Spread / Average Target
+6.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.86% | 41.09B | |
| +5.10% | 213B | |
| +3.60% | 177B | |
| +11.86% | 134B | |
| +16.66% | 99.13B | |
| +1.71% | 63.47B | |
| +16.98% | 53.69B | |
| -4.51% | 46.36B | |
| +11.39% | 39.3B | |
| +7.60% | 27.19B |
- Stock Market
- Equities
- A Stock
- News Agilent Technologies, Inc.
- Agilent Technologies : PharmDx Assay Receives Expanded Use in EU
